These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33176326)

  • 1. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
    Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
    Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Behavioral and Psychological Symptoms of Dementia.
    Bessey LJ; Walaszek A
    Curr Psychiatry Rep; 2019 Jul; 21(8):66. PubMed ID: 31264056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?
    Gurevich A; Guller V; Berner YN; Tal S
    J Nutr Health Aging; 2012; 16(6):557-61. PubMed ID: 22659997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
    Sturm AS; Trinkley KE; Porter K; Nahata MC
    Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.
    Kales HC; Lyketsos CG; Miller EM; Ballard C
    Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia.
    Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Stichele RV; Declercq T; Christiaens T
    J Am Med Dir Assoc; 2018 Nov; 19(11):1009-1014. PubMed ID: 30100234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caregiver Perspectives About Using Antipsychotics and Other Medications for Symptoms of Dementia.
    Kerns JW; Winter JD; Winter KM; Kerns CC; Etz RS
    Gerontologist; 2018 Mar; 58(2):e35-e45. PubMed ID: 28402533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
    Gareri P; De Fazio P; Manfredi VG; De Sarro G
    J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.
    Greenblatt HK; Greenblatt DJ
    J Clin Pharmacol; 2016 Sep; 56(9):1048-57. PubMed ID: 26953213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
    Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
    JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia Among Community Dwelling Adults.
    Trinkley KE; Sturm AM; Porter K; Nahata MC
    J Pharm Pract; 2020 Feb; 33(1):7-14. PubMed ID: 29695193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy in Treatment of Behavioral Issues in Dementia-Use of Atypical Antipsychotics.
    Jalil J; Nazarian P; von Walter HF
    Clin Geriatr Med; 2022 Nov; 38(4):641-652. PubMed ID: 36210081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.
    Haw C; Stubbs J; Yorston G
    Int Psychogeriatr; 2008 Aug; 20(4):790-9. PubMed ID: 18307825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients.
    Massot Mesquida M; Tristany Casas M; Franzi Sisó A; García Muñoz I; Hernández Vian Ó; Torán Monserrat P
    BMC Geriatr; 2019 Jan; 19(1):7. PubMed ID: 30621606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the number of behavioral symptoms in dementia and caregiver distress: what is the tipping point?
    Arthur PB; Gitlin LN; Kairalla JA; Mann WC
    Int Psychogeriatr; 2018 Aug; 30(8):1099-1107. PubMed ID: 29143722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
    Aupperle P
    Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.
    Lee PE; Gill SS; Freedman M; Bronskill SE; Hillmer MP; Rochon PA
    BMJ; 2004 Jul; 329(7457):75. PubMed ID: 15194601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.